[The possibilities of using the newest experimental results in the progressive myopia treatment].
Most recent experimental results concerning the pathomechanism of myopia are discussed. Anatomical, physiological, and biochemical changes taking place in the eye with experimental myopia are described. Special attention is focused on the following substances inhibiting the progress of experimental myopia: apomorphine, reserpine, 6-hydroxydopamine, atropine, pirenzepine, chlorpyrifos, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid, kainic acid, naloxane, formoguanamine, gentamicin, sodium iodate, central and peripheral antagonist of vasoactive intestinal polypeptide, basic fibroblast growth factor. The possibilities of the above-mentioned pharmacological agents in the progressive myopia treatment are indicated.
Czepita
D
D
Katedry Okulistyki, Pomorskiej AM w Szczecinie.
D000818:Animals; D003131:Combined Modality Therapy; D018450:Disease Progression; D006296:Health Services / Q000639:trends; D006801:Humans; D009216:Myopia / Q000209:etiology / Q000628:therapy*
Mozliwości wykorzystania wyników najnowszych badań doświadczalnych w leczeniu krótkowzroczności postepujacej.